Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder

Journal of the American Academy of Child and Adolescent Psychiatry
Paul GringrasRobert L Findling

Abstract

To assess the efficacy and safety of novel pediatric-appropriate, prolonged-release melatonin minitablets (PedPRM) versus placebo for insomnia in children and adolescents with autism spectrum disorder (ASD), with or without attention-deficit/hyperactivity disorder (ADHD) comorbidity, and neurogenetic disorders (NGD). A total of 125 children and adolescents (2-17.5 years of age; 96.8% ASD, 3.2% Smith-Magenis syndrome [SMS]) whose sleep failed to improve on behavioral intervention alone were randomized (1:1 ratio), double-blind, to receive PedPRM (2 mg escalated to 5 mg) or placebo for 13 weeks. Sleep measures included the validated caregivers' Sleep and Nap Diary (SND) and Composite Sleep Disturbance Index (CSDI). The a priori primary endpoint was SND-reported total sleep time (TST) after 13 weeks of treatment. The study met the primary endpoint: after 13 weeks of double-blind treatment, participants slept on average 57.5 minutes longer at night with PedPRM compared to 9.14 minutes with placebo (adjusted mean treatment difference PedPRM-placebo -32.43 minutes; p = .034). Sleep latency (SL) decreased by 39.6 minutes on average with PedPRM and 12.5 minutes with placebo (adjusted mean treatment difference -25.30 minutes; p = .011) ...Continue Reading

Citations

Jan 19, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yunho JinYonggeun Hong
Mar 3, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Annia GalanoRussel J Reiter
Apr 26, 2018·International Review of Psychiatry·Ritu GoelNa Young Ji
Aug 23, 2018·Journal of Child and Adolescent Psychopharmacology·Athanasios MarasPaul Gringras
Nov 22, 2018·Nature Reviews. Neuroscience·Ryan W Logan, Colleen A McClung
May 4, 2018·Archives of Disease in Childhood·Ibtihal Siddiq AbdelgadirAnthony K Akobeng
Jan 25, 2019·Journal of Child Neurology·Marian S McDonaghFrances Hsu
Sep 15, 2018·Endocrine Reviews·José Cipolla-Neto, Fernanda Gaspar do Amaral
Jul 28, 2019·Clinical Neuropharmacology·Semih Erden
Jan 7, 2020·The International Journal of Neuroscience·Ramanujam KarthikeyanSeithikurippu R Pandi-Perumal
Nov 5, 2019·Current Pharmaceutical Design·Luciana PinatoSanseray da Silveira Cruz-Machado
Feb 23, 2020·The FEBS Journal·Carina MarangaSimão Teixeira da Rocha
Aug 6, 2019·Frontiers in Endocrinology·Josephine Arendt
Sep 26, 2019·Journal of Child and Adolescent Psychopharmacology·Hannah E JohnsonKelly K Hill
Oct 23, 2019·Expert Opinion on Pharmacotherapy·Oliviero BruniRaffaele Ferri
Jul 24, 2020·European Child & Adolescent Psychiatry·Elin E KimlandAnastasia N Iliadou
Jun 5, 2020·CNS Drugs·Kevin A KaplanLorraine Potocki
Apr 16, 2019·Biological Research for Nursing·Ann E E JohanssonBernie Devlin
Jan 24, 2020·Cellular and Molecular Life Sciences : CMLS·Russel J ReiterLuiz G de Almeida Chuffa
Jul 30, 2020·Child Psychiatry and Human Development·Ruiting LiuJingping Zhao
Apr 9, 2019·BMJ Paediatrics Open·Aoife McDonald, Desaline Joseph
Jun 2, 2020·Frontiers in Psychiatry·Alexander DueckChristoph Berger
Oct 21, 2020·JAMA : the Journal of the American Medical Association
Jan 27, 2020·Journal of the American Academy of Child and Adolescent Psychiatry·Beth A MalowPaul Gringras
Jan 12, 2021·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Michelle SkrzelowskiDaniel J Berlau
Nov 11, 2020·Antioxidants·Nadia FerlazzoDaniela Caccamo
Feb 6, 2021·International Journal of Molecular Sciences·Sébastien LalanneSylvie Tordjman
Jul 21, 2020·Clinical and Experimental Pediatrics·Eun Kyeong Kang, Seung Soo Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.